The text starts here.

Corporate Information

Company Name Eisai Co., Ltd.
Date Established December 6, 1941
Head Office 4-6-10 Koishikawa, Bunkyo-ku, Tokyo 112-8088, Japan
Telephone 81-3-3817-3700
Representatives Haruo Naito, Representative Corporate Officer and CEO
Hideki Hayashi, Representative Corporate Officer, Corporate Planning & Strategy and CIO
Yutaka Tsuchiya, Representative Corporate Officer, Healthcare Policy and China Business
Hajime Shimizu, Representative Corporate Officer and CFO
Hideshi Honda, Representative Corporate Officer and Asia Region President
Capital 44,985 million Yen (as of March 31, 2014)
Sales Consolidated : 600,363 million Yen
Non-Consolidated : 341,766 million Yen
(The year ended March 31, 2014)
Scope of Business Manufacturing and marketing of prescription medicines and over-the-counter products
Employees Consolidated : 10,419
Non-Consolidated : 4,003 (as of March 31, 2014)
Communication Offices 64 Communication Offices in Japan (as of September 30, 2014)
Production Plants Kawashima Plant (Gifu Prefecture)
Kashima Business Office (Ibaraki Prefecture)
Sannova Co., Ltd. (Gunma Prefecture)
Eisai Inc. North Carolina Plant (U.S.A.)
Eisai Manufacturing Ltd. (U.K.)
Eisai China Inc. Suzhou Plant (China)
Eisai Pharmatechnology & Manufacturing Pvt. Ltd. (India), etc.
Laboratories Tsukuba Research Laboratories (Ibaraki Prefecture)
Kawashima Laboratory (Gifu Prefecture)
KAN Research Institute, Inc. (Hyogo Prefecture)
Eisai Inc. Andover Research Institute (U.S.A.)
Morphotek, Inc. (U.S.A.)
H3 Biomedicine Inc. (U.S.A.)
Eisai Ltd. Hatfield Research Institute (U.K.), etc.
Overseas Sales Offices Eisai Inc. (U.S.A.)
Eisai Ltd. (U.K.)
Eisai GmbH (Germany)
Eisai S.A.S. (France)
Eisai China Inc. (China)
Eisai Korea Inc. (South Korea), etc.

Related Links